US Physical Therapy Analyst Price Targets

Wall Street analyst price targets and consensus rating for US Physical Therapy (USPH).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

2S.Buy

4Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$104Upside to Avg. PT+26.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 11, 2026	JP Morgan	Benjamin Rossi	PT Raise	Overweight	$90→$95
Aug 10, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$90→$98
Jun 24, 2026	Citizens	Constantine Davides	Maintained	Market Outperform	$98
May 13, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$103→$90
May 8, 2026	Citizens	Constantine Davides	PT Cut	Market Outperform	$113→$98
Mar 10, 2026	Jefferies	Brian Tanquilut	Assumes	Buy	$102
Feb 20, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$103
Jan 5, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$103
Nov 24, 2025	JP Morgan	Benjamin Rossi	PT Cut	Overweight	$110→$100
Oct 24, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$103
Sep 18, 2025	JP Morgan	Benjamin Rossi	Assumes	Overweight	$110
Aug 8, 2025	Barrington Research	Michael Petusky	PT Raise	Outperform	$98→$103
Jul 1, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$98
Apr 22, 2025	JMP Securities	Constantine Davides	Maintained	Market Outperform	$113
Mar 19, 2025	JP Morgan	Calvin Sternick	PT Cut	Overweight	$120→$110
Feb 28, 2025	Barrington Research	Michael Petusky	PT Cut	Outperform	$108→$98
Dec 16, 2024	B of A Securities	Joanna Gajuk	Upgrade	Neutral→Buy	$100→$115
Dec 16, 2024	JMP Securities	Constantine Davides	Initiate	Market Outperform	$113
Dec 3, 2024	JP Morgan	Calvin Sternick	PT Raise	Overweight	$117→$120
Nov 21, 2024	Barrington Research	Michael Petusky	Maintained	Outperform	$108

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $90 to $98.

Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

Citizens analyst Constantine Davides reiterates US Physical Therapy (NYSE:USPH) with a Market Outperform and maintains $98 price target.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $103 to $90.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

Citizens analyst Constantine Davides maintains US Physical Therapy (NYSE:USPH) with a Market Outperform and lowers the price target from $113 to $98.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target

Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.

Benzinga Newsdesk

US Physical Therapy Inc

US Physical Therapy Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

PRO
Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

PRO
Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target

People Also Watch

People Also Watch

US Physical Therapy Inc

US Physical Therapy Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

PROBarrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

PROCitizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

PROBarrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

PROCitizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

PROBarrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

PRO
Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

PRO
Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

PRO
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $103 Price Target